CLONOMAB • Ricerca in generale (prima parte),PARIS
Executives - CLONOMAB Buy the executives list from same sector
M. Armand Bensussan
Consigliere Delegato (Gérant)
Key figures - CLONOMAB
Activities - CLONOMAB
Other classifications (for some countries)
NAF Rev.2 (FR 2008) : Research and experimental development on biotechnology (7211Z)
NACE Rev.2 (EU 2008) : Research and experimental development on biotechnology (7211)
ISIC 4 (WORLD) : Research and experimental development on natural sciences and engineering (7210)
NACE Rev.2.1 (EU 2025) : Research and experimental development on natural sciences and engineering (7210)
Kompass membership
| Kompass ID? | FRA00DRIX |
|---|
Key information - CLONOMAB
| Business unit | Headquarters |
|---|---|
| Year established | 2008 |
| Legal form | Société à responsabilité limitée (sans autre indication) |
| Activity (NAF08) | Research and experimental development on biotechnology (7211Z) |
| Corporate capital | 4’000 EUR |
| SIREN | 504 071 408 |
| SIRET (Siège) | 504 071 408 00034 |
| VAT no |
FR47 504071408 |
| No employees (address) | Information available as an option |
| No employees | Information available as an option |